Bristows
Expertise
Core sectors
Life sciences
Technology
Brands
Litigation
Patent litigation
Brands, designs & copyright
Commercial & technology
Competition litigation
Data breaches & cyber security
SEP/FRAND disputes
Media disputes
Judicial review
Transactions
Corporate & financing
IT & digital
Commercial & IP transactions
Employment
EU & UK merger control
Real estate
Tax
Regulatory & advisory
Competition advice & investigations
Data protection & privacy
Life sciences regulatory
TM & design portfolio management
Freedom to operate
Advertising & marketing
Charities & not-for-profit
Viewpoint
Articles
Events
News
Publications
People
Careers
Trainees
Current opportunities
Inclusion and Diversity
Life at Bristows
About us
A reputation for firsts
International reach
Awards
Corporate responsibility
Alumni
Compliance information
GDPR
Contact
toggle mobile menu
Home
Viewpoint
On the Pulse
Latest News
VIEW:
All topics
Artificial Intelligence
Brexit
Copyright
COVID-19
Digital Health
Digital Single Market
Employment / employers
Gene editing
Licensing
Open Technology
Patents
Trade marks
UPC
All sectors
Brands
Life sciences
Media & Entertainment
Technology
All practices
Advertising & marketing
Brands, designs & copyright
Brexit
Charities & not-for-profit
Commercial & IP transactions
Commercial & technology
Competition
Competition advice & investigations
Corporate & financing
COVID-19
Data breaches & cyber security
Data protection & privacy
Employment
EU & UK merger control
Freedom to operate
IT & digital
Judicial review
Life sciences regulatory
Media disputes
Patent litigation
Real estate
SEP/FRAND disputes
Tax
TM & design portfolio management
All dates
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
May 2013
MHRA warning about “certificates of compliance” & “Attestations of Compliance”
05.08.2020
Competition authorities continue to address excessive pricing in the pharmaceutical sector
23.07.2020
SPC manufacturing waiver: UK Government responds to call for views on draft legislation to fix issues in the Waiver Regulation post-Brexit
23.07.2020
UK Government opens consultation on the power to depart from EU case law
16.07.2020
Gilead’s remdesivir granted conditional Marketing Authorisation by the European Commission
03.07.2020
Webinar: Medical device regulation (MDR) and cyber security
29.06.2020
Further guidance from the Advocate General: ‘Pay-for-delay’ agreements
24.06.2020
Dickinson
Richard Dickinson
Partner
The Schmerzgel Redemption
22.06.2020
View more
